In patients admitted to hospital for coronary angiography, the use of drugs such as beta-blockers, statins, and angiotensin-converting-enzyme inhibitors was observed to be associated with significantly lower levels of MPO blood activity in patients with acute coronary syndrome, but not in patients with stable coronary syndrome. This evidence concerns the gene MPO and acute coronary syndrome.